✦ LIBER ✦

Single-Dose Pharmacokinetics and Pharmacodynamics of Sergliflozin Etabonate, a Novel Inhibitor of Glucose Reabsorption, in Healthy Volunteers and Patients With Type 2 Diabetes Mellitus

✍ Scribed by Hussey, Elizabeth K.; Clark, Richard V.; Amin, Dipti M.; Kipnes, Mark S.; O'Connor-Semmes, Robin L.; O'Driscoll, Eilis C.; Leong, Jenny; Murray, Sharon C.; Dobbins, Robert L.; Layko, Debbi; Nunez, Derek J. R.

Book ID: 121231605
Publisher: Sage Publications
Year: 2010
Tongue: English
Weight: 312 KB
Volume: 50
Category: Article
ISSN: 0091-2700
DOI: 10.1177/0091270009351879

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety, pharmacokinetics and pharmacodyn

Safety, pharmacokinetics and pharmacodynamics of remogliflozin etabonate, a novel SGLT2 inhibitor, and metformin when co-administered in subjects with type 2 diabetes mellitus

✍ Elizabeth K Hussey, Anita Kapur, Robin O’Connor-Semmes… 📂 Article 📅 2013 🏛 Springer (Biomed Central Ltd.) 🌐 English ⚖ 291 KB

Pharmacokinetics and Pharmacodynamics of

Pharmacokinetics and Pharmacodynamics of Canagliflozin, a Sodium Glucose Co-Transporter 2 Inhibitor, in Subjects With Type 2 Diabetes Mellitus

✍ Devineni, Damayanthi; Curtin, Christopher R.; Polidori, David; Gutierrez, Maria 📂 Article 📅 2013 🏛 Sage Publications 🌐 English ⚖ 605 KB

Pharmacokinetics and pharmacodynamics of

Pharmacokinetics and pharmacodynamics of dapagliflozin, a novel selective inhibitor of sodium–glucose co-transporter type 2, in Japanese subjects without and with type 2 diabetes mellitus

✍ S. Kasichayanula; M. Chang; M. Hasegawa; X. Liu; N. Yamahira; F. P. LaCreta; Y. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 705 KB

Safety, Pharmacokinetic, and Pharmacodyn

Safety, Pharmacokinetic, and Pharmacodynamic Profiles of Ipragliflozin (ASP1941), a Novel and Selective Inhibitor of Sodium-Dependent Glucose Co-Transporter 2, in Patients with Type 2 Diabetes Mellitus

✍ Schwartz, Sherwyn L.; Akinlade, Bola; Klasen, Sally; Kowalski, Donna; Zhang, Wen 📂 Article 📅 2011 🏛 Mary Ann Liebert 🌐 English ⚖ 322 KB

Safety, Tolerability, Pharmacokinetics,

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Rising Doses of Empagliflozin in Patients with Type 2 Diabetes Mellitus

✍ Tim Heise, Leo Seman, Sreeraj Macha, Peter Jones, Alexandra Marquart… 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 608 KB

First human dose-escalation study with r

First human dose-escalation study with remogliflozin etabonate, a selective inhibitor of the sodium-glucose transporter 2 (SGLT2), in healthy subjects and in subjects with type 2 diabetes mellitus

✍ Anita Kapur, Robin O’Connor-Semmes, Elizabeth K Hussey… 📂 Article 📅 2013 🏛 Springer (Biomed Central Ltd.) 🌐 English ⚖ 270 KB